Asim Sarfraz

Dr. Asim Sarfraz

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2022 in Cureus
Verified
Journal Article
Open access
SDSATISH Pundlik DIPANKAR
SATISH Pundlik DIPANKAR
TKTribhuwan Kumar
Tribhuwan Kumar
AIAfreen Begum H. Itagi
Afreen Begum H. Itagi
BNBijaya N. Naik
Bijaya N. Naik
YKYogesh Kumar
Yogesh Kumar
AKAmita Kumari
Amita Kumari
It is well known that some viral infections may affect male fertility. Coronavirus disease (COVID-19) can lead to multiorgan damage through the angiotensin-converting enzyme-2 receptor, abundant in testicular tissue. However, little information is available regarding the shedding of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in semen and its impact on spermatogenesis and fertility potential. We planned to investigate the presence of SARS-CoV-2 in the semen of COVID-19 males and to study the effect of COVID-19 on semen quality and sperm DNA fragmentation index. Thirty COVID-19 male patients aged 19-45 registered to AIIMS Patna hospital participated in the survey between October 2020 and April 2021. We conducted a real-time reverse transcriptase test on all the semen samples. Detailed semen analysis, including the sperm DNA Fragmentation Index, was done at first sampling that is during COVID-19. After 74 days of the first sampling, we obtained the second sampling and repeated all the above tests. All semen samples collected in the first and second sampling tested with real-time reverse transcription-polymerase chain reaction (RT-PCR) were negative for SARS-CoV-2. In the first sampling, semen volume, vitality, total motility, sperm concentration, total sperm count, % normal morphology, % cytoplasmic droplet, and fructose were significantly lower. In contrast, semen agglutination, % head defect, DNA Fragmentation Index, liquefaction time, semen viscosity, and leukocytes were increased. These findings were reversed at the second sampling but not to the optimum level. All these findings were statistically significant (p < 0.05 for all). Thus, COVID-19 negatively affects semen parameters, including sperm DNA fragmentation index. Although we could not find SARS-CoV-2 in the semen, the semen quality remained poor until the second sampling. Assisted reproductive technology (ART) clinics and sperm banking facilities should consider assessing the semen of COVID-19 males and exclude men with a positive history of SARS-CoV-2 until their semen quality returns to normal.

24 January 2025 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
KSKamal Singh
Kamal Singh
ZFZeeshan Farooque
Zeeshan Farooque
VGVIKRAM PAL GANDHI
VIKRAM PAL GANDHI
APApurva
Apurva
AKAman Kumar
Aman Kumar
BPBinod Kumar Pati
Binod Kumar Pati

17 August 2025 in Acta Clinica Belgica
Verified
Journal Article
Closed access
GAGargee Anand
Gargee Anand
RLRijhul Lahariya
Rijhul Lahariya
KPKetan Priyadarshi
Ketan Priyadarshi
ASAsim Sarfraz
Asim Sarfraz
To unmask the alarming prevalence, intricate antimicrobial resistance patterns, and consequential clinical outcomes of World Health Organization (WHO) priority pathogens causing device-associated infections in critical care settings - a frontier analysis of silent pandemic threatening modern healthcare. This groundbreaking retrospective study analysed data from 5,398 patients at risk for central line-associated bloodstream infections (CLABSI) and 15,416 patients for catheter-associated urinary tract infections (CAUTI) spanning 2021-2024. Microbial isolates were categorized according to WHO's priority pathogen classifications. Antimicrobial susceptibility profiles were comprehensively analysed using Clinical and Laboratory Standards Institute guidelines, with statistical analyses elucidating pathogen distribution dynamics, resistance mechanisms, and mortality correlations. Striking findings revealed WHO priority pathogens dominated the microbial landscape, constituting 76.47% of CLABSI and 82.14% of CAUTI isolates - with critical priority organisms overwhelmingly predominant (83.34% and 91.3%, respectively). Carbapenem-resistant Enterobacterales (CRE) emerged as the formidable leading threat (39.5% of CLABSI, 72.7% of CAUTI), while Carbapenem-resistant Acinetobacter baumannii (CRAB) demonstrated exceptional virulence with devastating mortality (93.33%). The study unveiled unprecedented levels of multidrug resistance, with most therapeutic options rendered ineffective; only colistin maintained universal efficacy against gram-negative isolates despite its concerning toxicity profile. Dramatic disparities in infection outcomes revealed CLABSI-associated mortality rates (71.79%) significantly eclipsed CAUTI (39.13%), establishing infection type as a critical independent predictor of survival. This landmark investigation exposes the crossroad between WHO priority pathogens and healthcare-associated infections, sounding an urgent alarm for global healthcare systems. Our findings provide crucial evidence-based guidance for recalibrating therapeutic approaches, optimizing antimicrobial selection, and prioritizing infection control measures in intensive care settings worldwide.

21 October 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
IHIsra Halim
Isra Halim
PSPrabhakar Singh
Prabhakar Singh
ASAsim Sarfraz
Asim Sarfraz
PKPrathyusha Kokkayil
Prathyusha Kokkayil
BPBinod Kumar Pati
Binod Kumar Pati
ARAmit Raj
Amit Raj
Fusarium species are among the most commonly isolated causes of fungal keratitis. Most species of the genus Fusarium belong to Fusarium solani species complex (FSSC). Fusarium lichenicola, a member of the FSSC complex, is a well-established plant and human pathogen. However, reports of fungal keratitis due to Fusarium lichenicola have not been frequently reported. To the best of our knowledge, only twelve cases of Fusarium lichenicola keratitis have been reported in the past fifty years. Clinical cases of Fusarium lichenicola may have most likely been misidentified because of the lack of clinical and microbiological suspicion, as well as inadequate diagnostic facilities in many tropical countries where the burden of the disease may be the highest. We report a case of fungal keratitis caused by Fusarium lichenicola and present a global review of the literature of all cases of fungal keratitis caused by this potentially blinding fungus.

3 September 2024 in Heliyon
Verified
Journal Article
Open access
SPSwathykrishna P.R
Swathykrishna P.R
BTBhaskar Thakuria
Bhaskar Thakuria
BPBinod Kumar Pati
Binod Kumar Pati
PKPrathyusha Kokkayil
Prathyusha Kokkayil
ASAsim Sarfraz
Asim Sarfraz
Automated results for determining colistin susceptibility tests are unreliable, micro broth dilution requires expertise, and CBDE has limited dilutions. International Consensus Document of 2022 suggested that agar dilution was unacceptable due to varying results in the literature. The study was designed to evaluate the agar dilution method for colistin susceptibility in CRE isolates compared to CBDE. In the study, 108 carbapenem-resistant isolates were tested for Colistin susceptibility by Microbroth Dilution, agar dilution, and colistin broth disc elution. The comparisons were made using various statistical parameters. The results of the agar dilution method revealed an essential agreement of 75 % and a categorical agreement of 92.5 %. The method showed a sensitivity of 75 % and a specificity of 97.7 %. The positive and negative predictive values were 88.2 % and 94.5 %, respectively. Youden's index was 0.727, indicating a moderate level of accuracy. Meanwhile, CBDE diagnostic accuracy tests were better, with Youden's index at 0.939. While CBDE demonstrated better accuracy parameters, it did not offer a broader MIC range. In contrast, agar dilution showed reasonable specificity and reliability for isolates with high MIC. Therefore, we propose using CBDE for screening and agar dilution as a supplementary test in the approach to colistin susceptibility.

17 June 2025
Verified
Journal Article
Open access
GAGargee Anand
Gargee Anand
RLRijhul Lahariya
Rijhul Lahariya
KPKetan Priyadarshi
Ketan Priyadarshi
ASAsim Sarfraz
Asim Sarfraz
Central line-associated bloodstream infections (CLABSI) remain a major contributor to morbidity and mortality in critically ill patients. The rise of antimicrobial resistance (AMR) exacerbates treatment challenges, making it crucial to examine pathogen resistance patterns. This study analyses CLABSI-associated pathogens’ antimicrobial susceptibility using the WHO’s AWaRe antimicrobial framework, providing insights to guide targeted treatment and strengthen infection control strategies. This observational study (2021–2024) assessed data from adult and pediatric ICUs to evaluate CLABSI incidence, microbial etiology, and antimicrobial susceptibility trends. We categorized antimicrobials based on the WHO’s AWaRe classification system, analysing their susceptibility to Access, Watch, and Reserve antimicrobials. Statistical analysis was performed using SPSS version 22. Among 5,398 patient records, 101 cases of CLABSI were confirmed. The predominant pathogens were Klebsiella (K.) pneumoniae (27.7%), Acinetobacter spp. (19.8%), and Candida spp. (17.8%). A worrying decline in susceptibility to Access- and Watch-category antimicrobials was observed in key pathogens. K. pneumoniae demonstrated a steep decline in susceptibility to Access-category agents, from 27.8% in 2021 to 16.7% in 2023. Conversely, Reserve-category antimicrobials maintained 100% efficacy across the study period. Acinetobacter spp. exhibited resistance to both Access- and Watch-category antimicrobials by 2024. Pseudomonas aeruginosa showed a drastic drop in Watch-category susceptibility, from 44.5% in 2021 to 0% in 2023, while Reserve-agents remained effective. These results underline the growing reliance on Reserve antimicrobials and the diminishing effectiveness of first-line agents. Furthermore, a fluctuation in CLABSI rates was also observed, with a significant reduction in infection rates in 2024 after the implementation of enhanced infection control practices. This study highlights the escalating resistance patterns of CLABSI pathogens, with a consternating decline in Access- and Watch-category antimicrobial efficacy. The AWaRe framework proves invaluable in identifying critical resistance trends, demonstrating the need for targeted antimicrobial stewardship. Prioritizing Access antimicrobials as first-line therapies, guided by local resistance data, can preserve the effectiveness of Reserve agents. A strategic focus on the AWaRe classification, coupled with rigorous infection control and stewardship programs, is essential to combat the rising AMR threat and optimize patient outcomes in critical care settings.